Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC
14 Sep 2024
Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC
OncoAlert Round Up for September 15-21, 2023
A reproducibility study in pulmonary adenocarcinomas supports a revised classification
The ABC Global Alliance’s work in improving the QoL for cancer patients
Social determinants of health in primary care
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
The importance of providing post-treatment care to cancer survivors
Cancer Survivorship